These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 18081738)

  • 1. Adipokines and cytokines in non-alcoholic fatty liver disease.
    Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.
    El Amrousy D; El-Afify D
    Cytokine; 2020 Nov; 135():155215. PubMed ID: 32731119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.
    Jamali R; Razavizade M; Arj A; Aarabi MH
    World J Gastroenterol; 2016 Jun; 22(21):5096-103. PubMed ID: 27275102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
    Jamali R; Arj A; Razavizade M; Aarabi MH
    Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of adipokines with obesity in children and adolescents.
    Jaleel A; Aheed B; Jaleel S; Majeed R; Zuberi A; Khan S; Ahmed B; Shoukat F; Hashim H
    Biomark Med; 2013 Oct; 7(5):731-5. PubMed ID: 24044565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
    Romanowska A; Lebensztejn DM
    Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS.
    Baltieri L; Chaim EA; Chaim FDM; Utrini MP; Gestic MA; Cazzo E
    Arq Gastroenterol; 2018; 55(3):247-251. PubMed ID: 30540086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
    Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
    Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
    Kashyap SR; Diab DL; Baker AR; Yerian L; Bajaj H; Gray-McGuire C; Schauer PR; Gupta M; Feldstein AE; Hazen SL; Stein CM
    Obesity (Silver Spring); 2009 Sep; 17(9):1696-701. PubMed ID: 19360015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease.
    Fitzpatrick E; Dew TK; Quaglia A; Sherwood RA; Mitry RR; Dhawan A
    Pediatr Obes; 2012 Dec; 7(6):471-9. PubMed ID: 22962039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
    Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.